Gene Query: HMOX2

Dataset Description Geneva Score
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 53.21
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 44.9
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 44.9
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 37.83
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 27.09
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 23.13
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 23.03
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 22.86
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 18.61
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 17.44
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 15.81
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 15.61
A transcriptome-wide divergence in protein translation scales with LIN28B expression 15.46
Stem and effector CD8 T-cells from human cancers 15.27
Genes regulated by SPDEF or FOXA3 in A549 lung carcinoma cells [RNA-seq] 15.08
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 14.92
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 14.69
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 14.54
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 14.28
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 14.15
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 13.81
Cajal bodies are linked to genome conformation 13.1
Cajal bodies are linked to genome conformation [RNA-Seq] 13.1
Generation of KRAS signatures using immortalized isogenic lung cells. 13.03
RNA-sequencing of pediatric idiopathic dilated cardiomyopathy patients and healthy controls 12.8
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 12.46
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 12.43
Morphological and molecular characterization of human dermal lymphatic collectors 12.43
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 12.05
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 11.46
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 11.46
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.2
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 11.19
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 11.19
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 11.14
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 11.14
Differentially expressed genes post knock down of lincDUSP26 11.07
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 10.98
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 10.98
H1609088 Human RNA-Sequencing 10.71
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 10.69
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 10.62
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 10.56
Genome wide expression change in LCC2 and MCF-7 cells 10.53
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 10.32
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 10.27
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 10.11
Zone dependent distinctive gene expression profile of the normal human liver tissue 10.02
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 9.9
Energy Metabolism during Anchorage-Independence 9.84
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 9.77
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 9.77
Human Treg NaCl stimulation 9.75
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 9.69
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 9.63
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 9.59
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 9.43
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 9.4
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 9.34
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 9.33
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 9.32
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 9.32
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 9.32
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 9.3
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 9.24
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 9.24
The human blood-nerve barrier transcriptome 9.13
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 9.1
CROP-Seq in Primary Human T Cells 8.93
Gene expression analysis of immortalized human liver progenitor-like cells in culture 8.87
RNA-sequencing of human liver tissue 8.85
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 8.84
Endothelial gene expression analysis 8.84
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.48
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 8.46
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.44
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 8.39
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 8.39
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 8.38
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 8.32
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 8.2
iRNA-seq: Computational method for genome wide assessment of acute transcriptional regulation from total RNA-seq data 8.13
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 7.99
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 7.96
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.93
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 7.91
BAF controls genome accessibility 7.88
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 7.88
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 7.88
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 7.78
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 7.76
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 7.74
Real-time observation of light-controlled transcription in living cells 7.72
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 7.7
Altering cancer transcriptomes using epigenomic inhibitors 7.7
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 7.7
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 7.62
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 7.62
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 7.62
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 7.59
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 7.51
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 7.51
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 7.49
Genome wide miR-191 target profile determined by RIP and gene expression profiling 7.49
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 7.49
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 7.46
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 7.44
The LRF/ZBTB7A transcription factor is a BCL11A-independent repressor of fetal hemoglobin 7.44
Control of prostate tumour growth by the long non-coding RNA GHSROS 7.38
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 7.38
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 7.38
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 7.33
mRNA expression profile of Lymphocytes 7.3
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 7.3
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 7.3
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 7.13
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 7.13
Transcriptional effect of ETV1 knockdown in melanoma cells 7.13
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 7.07
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 7.07
hTERT promotes cell adhesion and migration independent of telomerase activity 7.06
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.03
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 7.01
Tracking of dCas9-methyltransferase footprints 6.97
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 6.97
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 6.88
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 6.87
HNF1A deficiency impairs β-cell fate, granule maturation and function 6.85
Neurofibroma 6.85
Differential expression in wild-type and mutant neurofibroma and MPNST cell lines 6.85
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 6.85
Hijacking of stress response machinery by oncogenes in acute leukaemia 6.84
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 6.84
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 6.78
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 6.7
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 6.7
RNA-seq of cancer cell lines treated with T-025 6.66
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 6.62
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 6.61
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 6.51
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 6.5
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 6.48
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 6.46
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 6.45
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 6.41
Identification and Initial Functional Characterization of SENCR, a Long Non-Coding RNA Enriched in Human Vascular Cells 6.41
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 6.4
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 6.33
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 6.33
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 6.29
Transcriptome analysis in Neobractatin treated cells 6.27
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 6.23
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 6.21
Interferon-γ Converts Human Microvascular Pericytes into Negative Regulators of Alloimmunity through Induction of Indoleamine 2,3-Dioxygenase 1 6.18
Effect of nuclear IL-33 on gene expression 6.14
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 6.13
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 6.12
The evolution of N6-methyladenosine in primates 6.1
RNA-seq analysis of control and Myc-induced U2OS cells 6.07
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 6.07
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 6.05
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 6.01
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 5.99
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 5.98
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 5.98
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 5.96
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 5.96
Transcriptomic analysis of the HOTAIR-regulated genes 5.95
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 5.91
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.86
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 5.78
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 5.78
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 5.74
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 5.73
Regulation of protein translation during mitosis 5.72
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 5.7
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 5.67
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.66
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 5.66
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 5.64
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 5.63
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 5.61
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 5.58
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 5.57
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 5.57
The role of FAM46C in myeloma cells 5.56
The role of FAM46C in myeloma cells [sequencing] 5.56
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 5.56
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 5.51
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.5
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 5.49
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.49
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 5.47
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 5.46
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 5.46
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 5.44
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 5.44
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 5.42
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 5.42
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 5.4
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 5.39
Sauchinone controls hepatic cholesterol homeostasis by the negative regulation of PCSK9 transcriptional network 5.37
The landscape of alternative splicing in aggressive prostate cancers 5.37
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 5.33
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 5.33
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 5.31
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 5.31
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 5.29
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 5.26
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 5.24
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 5.2
Global transcriptome analysis of HAP1 cells 5.17
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 5.16
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 5.12
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 5.07
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 5.06
Neonatal and adult human testis defined at the single-cell level 5.06
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 5.04
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 4.99
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 4.94
Transcriptome profiling of 5 human adenocarcinoma cell lines 4.93
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 4.93
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 4.93
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.92
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 4.92
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 4.92
SNHG5 siRNA knock down in HCT116 cells 4.89
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 4.84
Effect of FGF13 depletion on the H460 cell line 4.81
mRNA expression profile of Lymphocytes by high-throuput sequencing 4.8
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 4.75
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 4.75
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 4.68
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 4.62
RNA seq comparison between scrambled and shGRP78 cells 4.61
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 4.58
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 4.44
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 4.44
RNAseq of T-ALL upon long non coding rna purturbation 4.42
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 4.4
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 4.39
N6-methyladenine DNA Modification in Glioblastoma 4.39
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 4.35
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 4.34
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.33
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.31
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 4.28
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 4.27
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 4.27
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 4.25
Non-coding regions are the main source of tumor-specific antigens [human] 4.24
Non-coding regions are the main source of tumor-specific antigens 4.24
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 4.24
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 4.21
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 4.14
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.12
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 4.1
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 4.09
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 4.09
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 4.09
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.07
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 4.04
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 3.98
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 3.98
BASP1 modifies the Tamoxifen response 3.97
MAIT cell RNA sequencing 3.93
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 3.93
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 3.91
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 3.86
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 3.86
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 3.84
Identification of HOXB13 target genes responsive to BET inhibitors 3.84
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 3.76
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 3.76
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 3.76
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 3.76
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 3.75
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 3.75
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.67
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.67
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.67
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 3.66
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 3.66
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 3.65
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 3.63
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 3.54
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 3.54
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 3.53
Transcriptomic analysis of human tonsillar TFH subsets 3.52
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 3.51
RNA-seq analysis upon ARID1B overexpression 3.46
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.43
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 3.42
Global gene expression differences between blood- and lymphatic-specific endothelial colony forming cells 3.4
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.4
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.4
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 3.4
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 3.37
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 3.37
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 3.37
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.36
miRNAs affected by antagomiR-17 treatment 3.34
Ribosome profiling upon inhibition of eIF4A 3.33
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 3.33
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 3.32
CHCHD2 gene KO effect in iPSC drived motor neurons 3.31
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 3.26
Transcriptome of human ILC2s; primary vs IL-1b-primed 3.21
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 3.21
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 3.17
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.13
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 3.12
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 3.12
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.11
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.1
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.1
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 3.1
Active translatome profiling with RiboLace in MCF7 cells 3.07
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 2.97
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.96
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 2.94
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling (mRNA) 2.94
High-throughput sequencing of PROMPT-enriched samples. 2.93
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 2.92
BET bromodomain inhibition 2.88
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 2.88
Hepatocyte maturation 2.87
RNA-sequencing of healthy human skeletal myocytes 2.87
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.86
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 2.86
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 2.81
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.81
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 2.8
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.79
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.78
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 2.73
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.73
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 2.71
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.68
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.68
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 2.64
Functional significance of the HIV-1 Tat signature amino acid residues 2.63
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 2.63
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.61
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 2.6
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 2.6
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 2.59
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 2.59
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 2.58
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.57
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.54
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.54
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.54
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 2.5
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 2.49
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.49
SLAM-seq for K562 endogenous mRNA decay 2.48
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 2.45
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 2.43
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 2.4
Transcriptome sequencing of K-562 cells 2.39
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.39
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 2.39
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.34
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 2.34
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 2.32
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.3
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 2.3
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 2.3
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 2.27
Transcriptome analysis of SKI knock-out in HL60 cells 2.27
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 2.19
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 2.19
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.19
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 2.18
Iron response of HepG2 cells 2.17
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 2.16
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.14
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 2.14
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 2.12
Illumina Total RNA-seq in HeLa 2.11
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 2.11
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 2.08
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 2.06
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.98
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.97
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.93
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 1.93
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 1.93
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 1.92
RNA-seq of cells with TET1 knockout 1.82
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.81
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.81
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 1.8
RNA expression analysis upon JMJD1C depletion 1.8
Effect of from Human Umbilical Vein Endothelial Cells 1.8
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.78
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.76
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 1.75
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 1.69
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 1.67
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 1.67
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 1.65
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.64
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.64
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 1.63
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.6
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.59
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.58
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 1.51
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 1.51
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 1.48
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 1.48
RNA-Seq of the corpus callosum from 12 individuals 1.47
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 1.4
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 1.4
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 1.37
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 1.37
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.35
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 1.34
Function and hormonal regulation of GATA3 in human first trimester placentation 1.25
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 1.25
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.25
Effect of BB608 on Gene Expression in HNSCC Cell Line 1.24
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.23
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.23
Identification of long noncoding RNAs in T-ALL cell lines 1.22
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 1.2
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.19
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.16
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.13
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.1
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 1.04
RNAseq of cell lines with knocked in ESR1 mutations 1.03
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.0
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.99
Hypoxic regulation of gene expression in HUVEC is dominated by EPAS1 0.95
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.94
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.91
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.88
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.86
The cohesin complex prevents Myc-induced replication stress 0.84
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 0.82
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.81
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.81
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.79
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.71
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.66
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.66
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 0.65
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.65
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.64
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 0.63
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.61
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.57
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.57
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.55
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 0.43
RNA-sequencing in immortalized human mammary epithelial cells 0.43
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.4
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.39
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.37
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.36
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.36
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.35
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.35
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 0.35
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.34
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.32
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium 0.3
Role of OSGIN1 in Mediating Smoking-induced Autophagy in the Human Airway Epithelium [RNA-Seq] 0.3
Total RNA-Seq data from leukemic patients with complex structural variants 0.29
Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD-linked Risk Locus 19q13.2 0.28
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 0.24
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 0.23
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.22
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.2
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.19
Kinetics of cytokine receptor trafficking determine signaling and functional selectivity 0.19
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.15
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 0.15
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.14
RNA seq analysis of human Fetal and adult derived Enterospheres 0.11
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.11
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.1
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 0.09
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 0.09
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 0.09
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 0.08
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 0.08
RNA-seq of shEZH2 cells 0.07
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 0.07
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.07
The circadian transcriptional landscape in primary human mammary epithelial cells 0.06
Gene expression changes due to PARP knockdown in human cells 0.06
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 0.06
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.03
Transcriptomic analysis of human macrophages in 3D 0.02
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.01
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation